Buy pharmaceutical chemicals online | pharmaceutical chemicals manufacturers | pharmaceutical chemicals suppliers - Worldofchemicals

chemical-categories

NLG919 analytical pure 0.992

NLG919 is a potent IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor with Ki/EC50 of 7 nM/75 nM in cell-free assays.

Suppliers
PI-103 analytical pure 0.983

PI-103 is a potent inhibitor with low IC50 values against recombinant PI3K isoforms p110alpha (IC50= 2 nM), p110beta (IC50= 3 nM), p110delta (IC50= 3 nM), and p110gamma (IC50= 15 nM), less potent to mTOR/DNA-PK with IC50 of 30 nM/23 nM.

Suppliers
PND-1186 analytical pure 98%

PND-1186 is a potent FAK inhibitor with IC50 of 1.5 nM.

Suppliers
RG2833 analytical pure 0.987

RG2833 is a brain-penetrant HDAC inhibitor with IC50 of 60 nM and 50 nM for HDAC1 and HDAC3, respectively.

Suppliers
RepSox analytical pure 0.999

RepSox is a potent and selective inhibitor of the TGFβR-1/ALK5 with IC50 of 23 nM and 4 nM for ATP binding to ALK5 and ALK5 autophosphorylation, respectively.

Suppliers
SAR405 analytical pure 0.982

SAR405 is highly potent and selective inhibitor of PIK3C3 with an IC50 of 27 nM.

Suppliers
SD-208 analytical pure 0.997

SD-208 is a potent, orally active ATP-competitive transforming growth factor-β receptor 1 (TGF-βRI) inhibitor (IC50= 49 nM) and displays > 100-fold and > 17-fold selectivity over TGF-βRII and other common kinases respectively.

Suppliers
SH-4-54 analytical pure 0.99

SH-4-54 is a potent, small molecule, nonphosphorylated STAT3 inhibitor with KD of 300 nM and 464 nM for STAT3 and STAT5, respectively.

Suppliers
SMI-4a analytical pure 0.996

SMI-4a is a potent inhibitor of Pim1 with IC50 of 17 nM, modestly potent to Pim-2, does not significantly inhibit any other serine/threonine- or tyrosine-kinases.

Suppliers
VE-821 analytical pure 0.994

VE-821 is a potent and selective ATP competitive inhibitor of ATR with Ki/IC50 of 13 nM/26 nM.

Suppliers

www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X